Drugs in the management of hypertension. Part III.
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D003981:Diazoxide / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005292:Ferricyanides / Q000627:therapeutic use*; D006146:Guanidines / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D008914:Minoxidil / Q000009:adverse effects / Q000627:therapeutic use; D009599:Nitroprusside / Q000009:adverse effects / Q000627:therapeutic use*; D011433:Propranolol / Q000009:adverse effects / Q000627:therapeutic use; D014294:Trimethaphan / Q000009:adverse effects / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D005292:Ferricyanides; D006146:Guanidines; D014665:Vasodilator Agents; D009599:Nitroprusside; D006830:Hydralazine; D008914:Minoxidil; D014294:Trimethaphan; D011433:Propranolol; D003981:Diazoxide